Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Oncternal Therapeutics, Inc. (ONCT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
23 Feb 2024
HALE DAVID F
Director
Oncternal Therapeutics, Inc.
(ONCT)
714
+368%
980
$9.04
$8,859.20
SELL
23 Feb 2024
Wills Robert James
Director
Oncternal Therapeutics, Inc.
(ONCT)
0
-100%
980
$9.04
$8,859.20
BUY
12 Jun 2023
Kaufmann Gunnar F.
Chief Scientific Officer, Officer
Oncternal Therapeutics, Inc.
(ONCT)
94,726
+41%
28,000
$0.35
$9,824.10
BUY
13 Apr 2023
VINCENT RICHARD G
Chief Financial Officer, Officer
Oncternal Therapeutics, Inc.
(ONCT)
156,859
+23%
30,000
$0.30
$8,961.00
BUY
13 Apr 2023
BREITMEYER JAMES B
Chief Executive Officer, Director, Officer
Oncternal Therapeutics, Inc.
(ONCT)
194,294
+338%
150,000
$0.29
$43,929.75
BUY
12 Apr 2023
Leavitt Chase C.
General Counsel/Secretary, Officer
Oncternal Therapeutics, Inc.
(ONCT)
106,901
+30%
25,000
$0.29
$7,250.00
BUY
12 Apr 2023
Yazji Salim
Chief Medical Officer, Officer
Oncternal Therapeutics, Inc.
(ONCT)
164,676
+17%
25,000
$0.29
$7,200.00
BUY
24 Mar 2022
VINCENT RICHARD G
Chief Financial Officer, Officer
Oncternal Therapeutics, Inc.
(ONCT)
88,162
+6%
5,000
$1.44
$7,210.38
BUY
27 Jan 2022
BREITMEYER JAMES B
Chief Executive Officer, Director, Officer
Oncternal Therapeutics, Inc.
(ONCT)
46,544
+116%
25,000
$1.68
$42,080.00
BUY
27 Jan 2022
VINCENT RICHARD G
Chief Financial Officer, Officer
Oncternal Therapeutics, Inc.
(ONCT)
83,162
+17%
12,500
$1.73
$21,625.00
BUY
27 Jan 2022
Leavitt Chase C.
General Counsel/Secretary, Officer
Oncternal Therapeutics, Inc.
(ONCT)
44,867
+43%
13,500
$1.72
$23,280.00
BUY
27 Jan 2022
Yazji Salim
Chief Medical Officer, Officer
Oncternal Therapeutics, Inc.
(ONCT)
67,137
+17%
10,000
$1.69
$16,900.00
SELL
30 Jun 2021
HALE DAVID F
Director
Oncternal Therapeutics, Inc.
(ONCT)
713,152
-0%
3,669
$4.75
$17,427.75
BUY
11 Jun 2021
Leavitt Chase C.
General Counsel/Secretary, Officer
Oncternal Therapeutics, Inc.
(ONCT)
1,500
+100%
1,500
$5.45
$8,175.00
BUY
1 Sep 2020
CARTER MICHAEL G
Director
Oncternal Therapeutics, Inc.
(ONCT)
71,947
+13789%
71,429
$2.10
$150,000.89
BUY
21 Jul 2020
KISNER DANIEL L
Director
Oncternal Therapeutics, Inc.
(ONCT)
10,000
+100%
10,000
$2.38
$23,825.00
BUY
21 Jul 2020
Shanghai Pharmaceutical (USA) Inc.
10% Owner
Oncternal Therapeutics, Inc.
(ONCT)
3,544,431
+42%
1,049,317
$2.38
$2,499,997.80
BUY
21 Jul 2020
AKER HAZEL M
Legal Counsel, Officer
Oncternal Therapeutics, Inc.
(ONCT)
46,987
+836%
41,972
$2.38
$99,998.29
BUY
13 Jul 2018
Young Diane C.
VP, Chief Medical Officer, Officer
GTX INC /DE/
(GTXI)
45,936
+0%
292.714
$102.90
$30,120.30
BUY
26 Jun 2018
Wills Robert James
Executive Chairman, Director, Officer
GTX INC /DE/
(GTXI)
137,344
+0%
714.286
$117.25
$83,750.00
SELL
20 Jun 2018
DOGGRELL HENRY PATTON
VP, Chief Legal Officer, Officer
GTX INC /DE/
(GTXI)
43,630
-2%
1,050.143
$133.04
$139,707.97
SELL
20 Jun 2018
Shackelford Jason T
Prin Fin. & Acct. Officer, Officer
GTX INC /DE/
(GTXI)
19,453
-6%
1,325.572
$133.04
$176,350.19
SELL
5 Jan 2018
DOGGRELL HENRY PATTON
VP, Chief Legal Officer, Officer
GTX INC /DE/
(GTXI)
54,804
-1%
709.286
$79.34
$56,276.83
SELL
5 Jan 2018
HANOVER MARC STEVEN
Chief Executive Officer, Director, Officer
GTX INC /DE/
(GTXI)
129,990
-0%
1,044.143
$79.34
$82,845.27
SELL
5 Jan 2018
Shackelford Jason T
Prin Fin. & Acct. Officer, Officer
GTX INC /DE/
(GTXI)
31,111
-1%
441.429
$79.34
$35,024.49
SELL
28 Oct 2016
Young Diane C.
VP, Chief Medical Officer, Officer
GTX INC /DE/
(GTXI)
0
-100%
7.143
$539.00
$3,850.00
BUY
14 Oct 2016
Pyramid Peak Foundation
10% Owner
GTX INC /DE/
(GTXI)
38,249,530
+0%
110,229.27
$56.70
$6,249,999.50
BUY
16 Jun 2016
Wills Robert James
Executive Chairman, Director, Officer
GTX INC /DE/
(GTXI)
1,200,000
+0%
1,428.571
$45.75
$65,360.00
BUY
1 Mar 2016
GLASS J KENNETH
Director
GTX INC /DE/
(GTXI)
183,767.58
+0%
628.571
$42.00
$26,400.00
BUY
26 Jan 2016
HANOVER MARC STEVEN
Chief Executive Officer, Director, Officer
GTX INC /DE/
(GTXI)
1,257,224
+0%
57.143
$45.50
$2,600.00
BUY
25 Jan 2016
HANOVER MARC STEVEN
Chief Executive Officer, Director, Officer
GTX INC /DE/
(GTXI)
1,253,224
+0%
183.043
$44.07
$8,067.06
BUY
19 Jan 2016
HANOVER MARC STEVEN
Chief Executive Officer, Director, Officer
GTX INC /DE/
(GTXI)
1,240,411
+0%
357.143
$34.80
$12,427.50
BUY
14 Jan 2016
HANOVER MARC STEVEN
Chief Executive Officer, Director, Officer
GTX INC /DE/
(GTXI)
1,215,411
+0%
357.143
$34.34
$12,265.59
Home